Skip to Content
Merck
  • Successful treatment of amoxapine-induced refractory status epilepticus with propofol (diprivan)

Successful treatment of amoxapine-induced refractory status epilepticus with propofol (diprivan)

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine (1995-02-01)
K S Merigian, R G Browning, K V Leeper
ABSTRACT

Tonic-clonic seizure activity is a recognized complication of amoxapine overdose. Refractory drug-induced status epilepticus is associated with significant morbidity and mortality. Standard regimens for controlling status epilepticus may be ineffective for aborting drug-induced seizures. The authors report the case of a 30-year-old woman who presented with an amoxapine overdose that deteriorated into status epilepticus refractory to conventional therapy. Propofol given by intravenous bolus and maintenance infusion successfully halted the patient's seizure activity. This case suggests that propofol may be effective as an anticonvulsant in refractory drug-induced status epilepticus.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Amoxapine